Summary of Significant Accounting Policies (Tables)
|
9 Months Ended |
Sep. 30, 2023 |
|---|
| Accounting Policies [Abstract] |
|
| Schedule of Other Receivables |
Other receivables consisted of the following for the periods presented:
|
|
|
|
|
|
|
|
|
As of |
|
|
September 30, 2023 |
|
|
December 31, 2022 |
|
Payroll tax withholding and exercise proceeds receivable |
$ |
31 |
|
|
$ |
273 |
|
Construction receivable |
|
7,600 |
|
|
|
6,199 |
|
Income tax receivable |
|
2,208 |
|
|
|
4,387 |
|
Insurance receivable |
|
3,771 |
|
|
|
2,627 |
|
Other |
|
1,377 |
|
|
|
1,696 |
|
Total other receivables |
$ |
14,987 |
|
|
$ |
15,182 |
|
|
| Schedule of Inventory |
Inventory consisted of the following for the periods presented:
|
|
|
|
|
|
|
|
|
As of |
|
|
September 30, 2023 |
|
|
December 31, 2022 |
|
Chemical washing solutions |
$ |
9,410 |
|
|
$ |
9,357 |
|
Reserve for obsolescence |
|
(188 |
) |
|
|
(183 |
) |
Total inventory, net |
$ |
9,222 |
|
|
$ |
9,174 |
|
|
| Schedule of Composition of Revenue |
The following table summarizes the composition of our net revenues for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Recognized over time |
$ |
167,670 |
|
|
$ |
150,873 |
|
|
$ |
489,294 |
|
|
$ |
440,809 |
|
Recognized at a point in time |
|
66,320 |
|
|
|
66,590 |
|
|
|
207,319 |
|
|
|
220,420 |
|
Other revenue |
|
86 |
|
|
|
113 |
|
|
|
317 |
|
|
|
925 |
|
Net revenues |
$ |
234,076 |
|
|
$ |
217,576 |
|
|
$ |
696,930 |
|
|
$ |
662,154 |
|
|
| Schedule of Reconciliations of Numerators and Denominators of Basic and Diluted Net Income Per Share |
Reconciliations of the numerators and denominators of the basic and diluted net income per share calculations for the periods presented are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
Net income |
$ |
19,485 |
|
|
$ |
23,997 |
|
|
$ |
67,753 |
|
|
$ |
95,144 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding - basic |
|
312,883,586 |
|
|
|
304,290,590 |
|
|
|
309,850,600 |
|
|
|
302,641,749 |
|
Effect of potentially dilutive securities: |
|
|
|
|
|
|
|
|
|
|
|
Stock options |
|
15,573,984 |
|
|
|
22,377,790 |
|
|
|
17,912,009 |
|
|
|
24,433,580 |
|
Restricted stock units |
|
289,840 |
|
|
|
154,987 |
|
|
|
463,687 |
|
|
|
678,005 |
|
Employee stock purchase plan |
|
97,159 |
|
|
|
57,785 |
|
|
|
39,582 |
|
|
|
20,010 |
|
Weighted-average common shares outstanding - diluted |
|
328,844,569 |
|
|
|
326,881,152 |
|
|
|
328,265,878 |
|
|
|
327,773,344 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share - basic |
$ |
0.06 |
|
|
$ |
0.08 |
|
|
$ |
0.22 |
|
|
$ |
0.31 |
|
Net income per share - diluted |
$ |
0.06 |
|
|
$ |
0.07 |
|
|
$ |
0.21 |
|
|
$ |
0.29 |
|
|
| Schedule of Antidilutive Shares Excluded from Computation of Diluted Net Income Per Share |
The following potentially dilutive shares were excluded from the computation of diluted net income per share for the periods presented because including them would have been antidilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Stock options |
|
3,798,034 |
|
|
|
2,384,530 |
|
|
|
3,343,733 |
|
|
|
2,188,289 |
|
Restricted stock units |
|
8,049 |
|
|
|
15,165 |
|
|
|
199,888 |
|
|
|
60,612 |
|
Employee stock purchase plan |
|
- |
|
|
|
7,186 |
|
|
|
30,594 |
|
|
|
34,466 |
|
|